Cardiol Therapeutics Inc (TSE:CRDL) (OTCQX:CRTPF) said Tuesday that its THC-free oral CBD formulation Cortalex is now available online through Shoppers Drug Mart’s Medical Cannabis by Shoppers portal. In a statement, the biotechnology company said there was “growing demand” from paediatricians and family physicians for a THC-free CBD formulation, but most CBD formulations currently available in Canada contain potentially psychoactive levels of THC and cannot be used by certain patient populations. Cortalex is the first pharmaceutically-produced CBD oil that is specifically formulated for patients who would benefit from the therapeutic effects of cannabidiol but should not take THC, such as children and young adults or seniors with chronic diseases.
Mackie Research Capital has initiated coverage of FansUnite Entertainment Inc. (CSE:FANS) (OTCMKTS:FUNFF) with a ‘Speculative Buy’ recommendation and a target price of $0.55 per share. In a note to clients, the Mackie analysts noted that potential catalysts for the stock include an expansion of B2B contracts and B2C platforms, the award of new licenses, revenue growth and M&A activity.
Todos Medical Ltd. (OTCQB:TOMDF) announced that it has received a notice of allowance from the European Patent Office covering the use of the company’s Total Biochemical Infrared Analysis (TBIA) platform to detect benign colon cancer in peripheral blood. The TBIA platform uses spectroscopy-based infrared analysis method to analyze immune cells in the blood or order to turn the biological information in the blood into data, and then mines that data using artificial intelligence to develop algorithms that are predictive of cancer and other diseases that impact the immune system, including bacteria and viruses. TBIA’s lead programs are in the detection of breast cancer and colon cancer.
Lucky Minerals Inc (CVE:LKY) (OTCMKTS:LKMNF) has outlined a large alteration area measuring around 2.8 kilometres by 2 kilometres at its Fortuna 4 concession in southern Ecuador. The so-called